Podcasts about CMS

Cypherpunk and Other Stuff Transmitted By Relays: Nostr sa mi nepáčil, keď vyšiel. Príliš základný, nie veľmi dobré súkromie, nie veľmi decentralizovaný. Stále preň ale píšem ďalšie a ďalšie appky. Decentralizované mapy, decentralizované eventy, plánovanie, marketingové nástroje, anonymné mikroblogy. Iní postavili veci ako decentralizovanú inferenciu alebo súkromné správy. Nostr je skratka pre Notes and Other Stuff Transmitted by Relays. Prednáška sa sústredí na to Other Stuff a na to, ako posúva cypherpunkovú budúcnosť do dneška. Nostrautica – pre udalosti a komunity, aby sa ľudia v rámci nich spoznali. Pridajte sa do komunity podcastu Reči o živote, vesmíre a vôbec! Lunarpunk – záznamy z ostatných prednášok z Košíc Appka Bitblik Appka Routstr – a moja node routstr.cypherpunk.today. AI inferencia bez KYC a bez predplatného Roadstr – decentralizované mapy Appky Lievik a Nostr Emanator Eso Level Estimator 8000 nsite-clay – hosting a CMS – samoeditovateľné stránky bez e-mailu, hostované na Nostri Zapstore – app store nad Nostr Git cez Nostr Bezpečná chatovacia appka WhiteNoise – cez Nostr

The back-and-forth between CMS leaders continues. President Donald Trump stumps in Gastonia for Republican U.S. Senate candidate Michael Whatley. Charlotte City Council may reverse its vote opposing the I-77 toll lanes, and the Women's Tennis Association is moving its headquarters to Charlotte. Those stories and more with our roundtable of reporters.

1.    Victoria ambiental en Ranchos Guayama de Salinas: acuerdo del DRNAestablece $61,000 en sanciones y multas, medidas de mitigación y paraliza campode tiro de CODEPOLA en zona residencial. Quedan al lado de comunidad Cimarrona,a la que le tiran material de AES, según denunciantes2.    Inicia el juicio de manifestantes de La Parguera. El martes comienza enel Tribunal de Mayagüez el juicio contra los manifestantes golpeados yarrestados por la Policía en la protesta por la construcción en la caseta delos suegros de la gobernadora en La Parguera3.    Nuevos actores se suman al elenco de “Porto Rico”, película deResidente, la que el gobierno de PR no quiso ayudar y se está filmando en RD4.    Gobernadora pide a CMS reconsiderar regla que podría reducir pagos amédicos5.    Las mujeres pierden poder en el mundo, según un informe de la ONU6.    Lady Gaga y Michael Polansky tuvieron una hija, y se llama Rose Bean 7.    ONU: el aparato represivo de Venezuela continúa "intacto"8.    Nepal añade mil nuevos desaparecidos para un total de 6,000 a tressemanas de la riadaEste es un programa independiente y sindicalizado. Esto significa que este programa se produce de manera independiente, pero se transmite de manera sindicalizada, o sea, por las emisoras y cadenas de radio que son más fuertes en sus respectivas regiones. También se transmite por sus plataformas digitales, aplicaciones para dispositivos móviles y redes sociales.  Estas emisoras de radio son:1.    Cadena WIAC - WYAC 930 AM Cabo Rojo- Mayagüez2.    Cadena WIAC – WISA 1390 AM Isabela3.    Cadena WIAC – WIAC 740 AM Área norte y zona metropolitana4.    X61 – 610 AM en Patillas5.    X61 – 94.3 FM Patillas y todo el sureste6.    WPAB 550 AM - Ponce7.    ECO 93.1 FM – En todo Puerto Rico8.    WLRP 1460 AM Radio Raíces La voz del Pepino en San Sebastián9.    WOQI 1020 AM – Radio Casa Pueblo desde Adjuntas 10. Mundo Latino PR.com, la emisora web de música tropical y comentario Una vez sale del aire, el programa queda grabado y está disponible en las plataformas de podcasts tales como Spotify, Soundcloud, Apple Podcasts, Google Podcasts y otras plataformas https://anchor.fm/sandrarodriguezcotto También nos pueden seguir en:REDES SOCIALES:  Facebook, X (Twitter), Instagram, Threads, LinkedIn, Tumblr, TikTok BLOG:  En Blanco y Negro con Sandra http://enblancoynegromedia.blogspot.com  SUSCRIPCIÓN: Substack, plataforma de suscripción de prensa independientehttps://substack.com/@sandrarodriguezcotto OTROS MEDIOS DIGITALES: ¡Ey! Boricua, Revista Seguros. Revista Crónicas y otrosEstas son algunas de las noticias que tenemos hoy En Blanco y Negro con Sandra. 

A short-term home health and moratorium was a necessary action because of rampant fraud in the hospice sector, said Tom Koutsoumpas, founder and CEO of the National Partnership for Healthcare and Hospice Innovation (NPHI). Still, the moratorium, which is designed to contain and address egregious activities, is meant to be a short-term solution, said Koutsoumpas, who was involved when the benefit was created in the 1980s. There has been an overreaction during the moratorium, he noted, and acknowledged that some of his members have been subject to unnecessary audits. While the question of the moratorium has divided provider organizations, more imperative is that the community as a whole support and encourage the Centers for Medicare & Medicaid Services in their fraud-fighting efforts, he said. The organization's support of the moratorium and may be one reason why NPHI has experienced a surge of new members of late. On another subject, he is excited about the attention palliative care has been receiving from CMS in rulemaking. NPHI has proposed a palliative care model that would be adjacent to the hospice benefit. More details are forthcoming, he said.Follow us on social media:X: @McKHomeCareFacebook: McKnight's Home CareLinkedIn: McKnight's Home CareInstagram: mcknights_homecareFollow NPHI on social media:X: @NPHIhealthFacebook: National Partnership for Healthcare and Hospice InnovationLinkedIn: National Partnership for Healthcare and Hospice Innovation (NPHI)Show contributors:McKnight's Home Care Editor Liza Berger; Tom Koutsoumpas, founder and CEO, National Partnership for Healthcare and Hospice Innovation (NPHI) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

More than seven million Americans live with Alzheimer's disease today, a number projected to nearly double by 2060. It already consumes 20% of all Medicare spending and costs the economy close to half a trillion dollars annually. But the science is finally catching up. Newt is joined by former CDC Director Dr. Robert Redfield and Dr. Brent Beasley, a retired internist who was diagnosed with Alzheimer's at age 57, for a conversation about new blood tests that detect the disease early and what treatments are being developed. Dr. Redfield draws on his decades leading America's response to the HIV/AIDS epidemic to argue that Alzheimer's disease demands the same sense of urgency. Dr. Beasley shares his remarkable personal journey: how an early blood test and a new monoclonal antibody treatment reversed his decline. Together, they lay out the five policy changes needed now, from routine blood testing for everyone over 50 to removing CMS barriers blocking access to approved treatments, including passage of the bipartisan ASAP Act, which would create a Medicare pathway for FDA-cleared blood-based Alzheimer's biomarker tests.See omnystudio.com/listener for privacy information.

Scott and Wes dig into a listener mailbag full of AI questions: how to bill freelance work when the tools make you faster, whether coding still matters in interviews, and if the AI bubble is about to pop. Plus sandboxing your agents, managing block-based CMS chaos, and what it takes to leave a stable job when you're risk averse. Show Notes 00:00 Welcome to Syntax! 01:09 Freelance Billing in the Age of AI: Who Gets the Speed Savings? 04:33 Value Based Pricing and Leveling Up Your Skills 06:37 Will Writing Code Become Irrelevant in Job Interviews? Ghostty, Superlogical Better Auth 11:05 Finding Human Answers in a Sea of AI Slop 14:57 Trust and Community Are the New Currency 15:49 Nobody Watches Conference Talks Anymore AI Engineer 18:18 Is the AI Bubble Going to Pop? The AI Bubble Survives on $1.65 Trillion in Hidden Debt 24:07 Where Is All the Software AI Was Supposed to Build? 26:19 AI Fatigue: When All You Do Is Review Code True Cost of AI Coding 30:03 Managing Large Block Based CMS Systems Fimo Sanity 38:57 Taking the Leap: Leaving a Stable Job as a Risk Averse Dev 43:45 Sandboxing Your Agents Instead of Running YOLO Mode CJ's Video: Every Developer Should Know This Docker 45:38 Will AI Companies Fingerprint and Ad Target You? Colemak Web Audio API Brave on X 49:36 Labeling YouTube Exclusive Episodes for Podcast Listeners 52:16 Sick Picks + Shameless Plugs Sick Picks Scott: Sandpaper Pads, Jellyfin, Apps2Samsung Wes: Hisense TV Hit us up on Socials! Syntax: X Instagram Tiktok LinkedIn Threads Wes: X Instagram Tiktok LinkedIn Threads Scott: X Instagram Tiktok LinkedIn Threads Randy: X Instagram YouTube Threads

ChatGPT Is Inside Epic, 40 Mergers in Six Months, and 92% Bracing for StrainThree stories, one direction. Technology is accelerating, consolidation is accelerating, and the people running health systems have stopped waiting to see how it shakes out.

Send us Fan MailMany physicians begin their careers with a passion for patient care, only to discover that creating meaningful change often requires leadership beyond the exam room. Whether leading teams, influencing healthcare policy, mentoring future physicians, or driving organizational transformation, today's physician leaders are shaping the future of healthcare in powerful ways. Our guests today, Dr. Yumi Taylor and Dr. Sharon Tapper, are nationally respected physician leaders who have dedicated their careers to advancing patient care, supporting physician development, and creating healthier healthcare systems. Through their leadership and their work with Hottocare, they are helping bring one of the most innovative new Medicare programs to patients and families across the country—the GUIDE (Guiding an Improved Dementia Experience) Model. This groundbreaking CMS initiative recognizes that effective dementia care requires support not only for patients, but also for the family caregivers who often shoulder enormous emotional, physical, and financial responsibilities. In this episode, we'll explore leadership in medicine, the growing impact of dementia on our healthcare system, how the GUIDE Model is transforming dementia care, and what physicians need to know about connecting patients and caregivers with these valuable resources as the program expands nationwide.Please Follow or Subscribe to get new episodes delivered to you as soon as they drop! Visit Jill's company, Health e Practices' website: https://healtheps.com/ Subscribe to our newsletter, Health e Connections: https://share.hsforms.com/1FMup6xLPSpeA8hB77caYQwd32sx?hsCtaAttrib=171926995377 Want more formal learning? Check out Jill's newly released course: Physician's Edge: Mastering Business & Finance in Your Medical Practice. 32.5 hours of online, on-demand CME-accredited training tailored just for busy physicians. Promo pricing available now: https://education.healtheps.com/offers/Ry3zfLYp/checkout?coupon_code=PHYSEDGE3000 Purchase your copy of Jill's book here: Physician Heal Thy Financial Self Join our Medical Money Matters Facebook Group here: https://www.facebook.com/groups/3834886643404507/ Original Musical Score by: Craig Addy at https://www.underthepiano.ca/ Visit Craig's website to book your Once in a Lifetime music experience Podcast coaching and development by: Jennifer Furlong, CEO, Communication Twenty-Four Seven https://www.communicationtwentyfourseven.com/    

This week I Answer Listener Questions [powerpress]

We break down the FY 2027 Hospice Final Rule and why CMS is becoming increasingly more aggressive in oversight tied to program integrity and beneficiary protection. We walk through the increase in non-hospice spending, and finalized the new SSVI risk scoring model.CMS's stronger focus on hospice accountability, transparency, and beneficiary protectionsRapid growth in non-hospice spending under Parts A, B, and D, and why CMS is targeting itBeneficiary cost-sharing concerns and how “leakage” can happen with facility partnersHow the SSVI is calculated and what a higher score can triggerElection statement addendum becoming required for every Medicare patient beginning 10/1/2026, and why relatedness documentation must be airtightTelehealth face-to-face flexibility extended through 2027, plus new 2027 claims reporting codesCare Compare icon tied to HQRP participation SSVI blog and fact sheet is available for you to downloadVisit our websiteConnect with us - LinkedIn, Twitter, YouTube, FacebookMake Lives Better

Send us Fan Mail2027 is not one reimbursement change. It's multiple changes moving at different speeds, some proposed, some confirmed, and the most expensive mistake is treating all of them like the same fee-schedule cut. Change 1, Medicare rates: CMS has proposed two 2027 conversion factors. The headline percentage is never your practice's percentage. Model your own top codes. Change 2, global procedures: Same-day E/M billed with a global procedure is getting more scrutiny. Documentation, not billing habit, decides whether it survives an audit. Change 3, specialty codes: New 2027 OB/GYN coding replaces the bundled global obstetric payment. The pattern applies to every specialty as codes get more specific. Change 4, digital care: Remote monitoring reimbursement is becoming more conditional on established-patient status, a documented initiating visit, and employed clinical staff. Change 5, rate transparency: Federal transparency files make commercial negotiated rates newly accessible, setting up next episode's data methodology. Three actions this week: Pull your top 20 Medicare CPT codes by allowed dollars Check whether your practice bills E/M on the same day as global procedures, and audit the documentation If you run remote monitoring, confirm employed clinical staff and a documented initiating visit Episode breakdown 00:00 Hook 00:40 The 2027 reframe 03:00 Change 1: Medicare rate nuance 07:00 Change 2: Global procedure scrutiny 11:00 Change 3: OB/GYN as the specialty example 15:00 Change 4: Digital care conditions 18:00 Change 5: Rate transparency 20:00 The three-question diagnostic 23:00 Close and next episode Resources 2027 Revenue Impact Brief: eligibility.natrevmd.com/know-where-2027-will-impact-your-practices-revenue-free-brief-natrevmd Metrics Audit Review (free, physician-led): eligibility.natrevmd.com/metrics-audit-natrevmd Website: natrevmd.com Referenced: EP210, the Modifier 25 framework Coming next: EP214, the one number to know before you negotiate with a payer 

CMS chief operating officer Kim Brandt and CIO Patrick Newbold say a new culture of delivering IT capabilities and scaling them quickly is taking holdSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

CDI, coding, and clinical medicine are involved in a tug-of-war over a complex, life-threatening medical emergency that seems resistant to all forms of consensus. I'm talking about sepsis of course, and on today's show I got to talk about sepsis with someone as qualified as anyone in the world to do so. Steven Simpson, MD, is Professor of Medicine at the University of Kansas in the Division of Pulmonary, Critical Care, and Sleep Medicine. He has done research in all areas of severe sepsis, from molecular and cellular mechanisms to translational and quality improvement studies. He is currently chair of the board of directors for the Sepsis Alliance and an author of the 2016, 2021, and 2025 reviews and updates of the Surviving Sepsis Campaign Guidelines. I'm also joined by James Kennedy, MD, CCS, a familiar name and voice for anyone involved in CDI and coding circles. Listen in as we cover: Dr. Simpson's deep and rich background in sepsis, including early clinical days with septic patients, working with Drs. Bone and Balk who created Sepsis-1, and his role on the Sepsis Alliance. Co-authoring the 2026 Surviving Sepsis Guideline that defines sepsis as a “life-threatening acute organ dysfunction to infection”: His stance on sepsis-2 and sepsis-3. The politics of definition and diagnosis: Who gets to write these definitions. The struggle: Reconciling sepsis-2 with sepsis-3, further complicated by CMS' use of sepsis-2 in its new sepsis readmission measure. What's the right answer for this, if there is one? Looming sepsis proposal to create codes for “impending sepsis,” the role of AI-technologies (e.g., Sepsis ImmunoScore, TriVerity) in identifying these patients, and what the University of Kansas is doing to identify and intervene on infected patients before they evolve into organ dysfunctions. Plans for future work for other sepsis-related concepts, payers and denials, and a pair of songs for the Off the Record Spotify playlist.

Oscar Health looks like a screaming buy — growing revenue, growing members, positive free cash flow. So why does the market keep discounting it? We ran the numbers.Oscar Health (OSCR) just posted strong headline numbers: member growth accelerating past 3 million, revenue climbing, free cash flow positive. Health insurers don't get valued like typical growth stocks — and free cash flow is one of the most misleading metrics you can use here.In this episode, we break down why insurance float — not free cash flow — is the real driver of Oscar's balance sheet, how the medical loss ratio (MLR) caps profitability by regulation, and why receivables and payables to CMS matter more than most investors realize. We also walk through two reverse DCF scenarios on GAAP earnings per share — a 10-year model and a more aggressive 3-year model — to see what growth rate the market is actually pricing into OSCR today.Think of it as a masterclass in valuing any financials-driven business — insurance, banks, specialty finance — differently than you'd value a software or semiconductor company. We also give a first look at the new investment thesis checklist tool and segment/KPI dashboard inside Semiconductor Insider.TIMESTAMPS0:00 - Why Oscar Health Looks Cheap (And Why That's Misleading)1:04 - Revenue, Member Growth & Free Cash Flow Overview2:00 - The Problem: Free Cash Flow Isn't Real Cash Flow Here2:40 - Medical Loss Ratio Explained: The 80% Rule3:03 - Insurance Float 101 (The Berkshire Hathaway Playbook)4:38 - Reading the Balance Sheet: Premiums, Payouts & SG&A5:24 - CMS Receivables & Payables: The Hidden ACA Liability7:00 - Reverse DCF: 10-Year vs. 3-Year Growth Scenarios9:07 - Building a Custom Investment Thesis Checklist10:40 - Final Takeaway: How to Actually Value Oscar Health—If you want the reasoning behind more names like this one, Semiconductor Insider covers the process in more depth. Get access to all our research, weekly live Q&A events, and a growing set of tools to build your process: https://www.chipstockinvestor.comAll our socials: https://linktr.ee/chipstockinvestorIf you're getting value from the show, follow so you don't miss the next one.—Disclosure: Some links above are affiliate links. If you buy something through them, we might earn a little coffee money — thanks for helping us (Kasey) fuel our caffeine addiction.Content in this episode is for general information or entertainment only and is not specific or individual investment advice. Forecasts and information presented may not develop as predicted, and there is no guarantee any strategies presented will be successful. All investing involves risk, and you could lose some or all of your principal. CSI doesn't own shares of Oscar Health.

This episode breaks down the upcoming sleep testing code changes and why they matter for sleep labs, physicians, technologists, vendors, and health systems. The STT Crew discuss how the new structure changes home testing, professional review, reimbursement, and patient triage.They also explain why so many people in sleep care still do not realize these changes are coming, and what teams should be doing now before the January 2027 rollout.Key topicsIn this episode, the hosts explain that the current home sleep testing codes are set to sunset at the end of the year, with a new framework expected to launch January 1, 2027.The Crew lays out the new home testing tiers:Low complexity — 3 to 4 channels, CPT 95X18Moderate complexity — 5 to 10 channels, CPT 95X19High complexity — 11 plus channels, CPT 95X20, which includes home PSGTimestamps(00:00) Sponsor messages and episode setup(02:02) Introducing the new PSG code changes(02:59) Why most sleep professionals missed the coming changes(04:15) Fragmented communication in sleep care(05:42) Technical and professional billing are separating(06:42) Home PSG and the new high-acuity testing tier(08:16) Why physicians may need to review more than AHI(09:41) Why vendors cannot yet define the new channels(10:50) What sleep providers should do right now(11:20) Early reimbursement estimates and operational concerns(12:31) Derived channels, device selection, and policy updates(13:23) Payer contracts and vendor agreements may need revision(14:45) The three home testing complexity tiers(16:15) Why in-lab sleep testing is not going away(17:13) CMS, utilization control, and triage strategy(20:07) More data at home, more access to care(23:36) Hospital screening and inpatient sleep apnea risk(25:22) Population health outreach using AI and EHR data(27:57) Final takeaways on preparation, uncertainty, and timing(31:02) Important dates — comment period, November release, January 1 launchShare your opinion and comment on the codes here:https://aasm.org/new-unattended-sleep-testing-cpt-codes-cms-proposed-rule/ A huge thanks to our sponsors:Fisher & Paykel Healthcare  Discover how F&P full-face masks have led millions of people to a great night's sleep at https://www.fphcare.com/curiosityhttps://www.fphcare.com/us/homecare/sleep-apnea/Philips Healthcare   See how Philips is supporting you and your patients with meaningful innovation. Visit https://www.philips.com/matters Soliish https://www.soliish.com/React Health  https://www.reacthealth.com/More resources for clinicians can be found at Sleep Review Magazine  https://sleepreviewmag.com/Credits:Audio/ Video: Diego R Mannikarote; Music: Pierce G MannikaroteHosts: J. Emerson Kerr, Robert Miller, Gerald George MannikaroteCopyright: ⓒ 2026 SleepTech Talk ProductionsEpisode 131The views and opinions expressed by guests on SleepTech Talk are their own and do not necessarily reflect those of the podcast hosts or SleepTech Talk as a whole. This podcast is intended for educational and informational purposes only and should not be considered medical advice. Listeners are encouraged to consult with a qualified healthcare professional for any medical concerns or questions.

Vivek Garg, MD, President and CEO of the National Committee for Quality Assurance (NCQA), joins Josh Israel, MD and Sean Cavanaugh to talk about the future of quality measurement in healthcare. While acknowledging clinician frustration with sometimes fragmented or conflicting quality metrics, Dr. Garg shares NCQA's strategy to harmonize CMS quality measurement frameworks including the new Advanced Primary Care (APC) program. APC leverages interoperable data and outcome-oriented signals to align healthcare stakeholders in value-based care. Ultimately, the goal is to shift to a measurement system that supports primary care clinicians in delivering high-quality, patient-centered care that rewards clinicians for improving patient outcomes.

You have less than one month to submit your thoughts or questions about the proposed 2027 Medicare physician fee schedule to CMS. The comment period will end Sept. 14, 11:59 p.m., ET. To be part of the reimbursement process you need to be heard! CMS must read every comment it receives by the deadline and include a response in the final rule. Therefore, submitting a comment is more than a way to share your opinion: you can make suggestions and ask questions.The fastest way to submit a comment is online at www.regulations.gov/docket/CMS-2026-2377. Click the “Open for comments” button on the left, scroll down to the “Comment” button on the lower right and follow the instructions.Terry goes over some of the Final Rule 2027 highlights and encourages all stakeholders to send in your comments now!

Greg Etzel, Partner, Morgan Lewis & Bockius LLP, and Eric Lucas, Managing Director, Baker Tilly, discuss the latest trends and developments related to Medicare cost reporting and appeals. They cover why the Medicare cost report still matters and how it has changed over the years, recent litigation surrounding the cost report, how the wage index impacts hospital reimbursement, issues related to CMS' low wage index policy and1985 budget neutrality adjustment, the biggest procedural traps for hospitals, and reopening old cost reports. Greg and Eric spoke about this topic at AHLA's 2026 Institute on Medicare and Medicaid Payment Issues in Baltimore, MD.Watch this episode: https://www.youtube.com/watch?v=fYR5n1JL-8ALearn more about AHLA's 2026 Institute on Medicare and Medicaid Payment Issues: https://www.americanhealthlaw.org/medicaremedicaidLearn more about AHLA's 2026 Medicare and Medicaid eProgram: https://educate.americanhealthlaw.org/local/catalog/view/product.php?productid=1759 Essential Legal Updates, Now in AudioAHLA's popular Health Law Daily email newsletter is now a daily podcast, exclusively for AHLA Comprehensive members. Get all your health law news from the major media outlets on this podcast! To subscribe and add this private podcast feed to your podcast app, go to americanhealthlaw.org/dailypodcast.Stay At the Forefront of Health Legal EducationLearn more about AHLA and the educational resources available to the health law community at https://www.americanhealthlaw.org/. 

In this episode, healthcare attorneys Joella Roland and Jason Reddish from Powers join to provide commentary on a variety of developments impacting 340B covered entities. They'll discuss ongoing manufacturer activity, from contract pharmacy restrictions to claim data submission requirements, and how 340B providers have been responding. They'll also share some opinions on how recent judicial rulings on HRSA policy, including child site eligibility timing and GPO Prohibition, have impacted regulatory enforcement of the 340B Program. They'll also offer some thoughts on how recent proposed CMS rules related to Medicare Part B billing and Medicare Part D 340B data collection will impact covered entities in the future. In the intro, Greg and Rob recap changes that have been made to the HRSA Data Request List for FY27. Save the date for our upcoming 340B CE webinar on Tuesday, September 29th. Questions?  Email us at 340BUnscripted@spendmend.com

This week I Talk About The Next WordPress Job Titles [powerpress]

This week I Talk About The Next WordPress Job Titles [powerpress]

CMS's permanent rule on virtual supervision is reshaping how imaging centers manage contrast procedures. Discover the compliance requirements, the role of real-time video coverage, and the potential operational benefits. Learn more at https://www.contrast-connect.com/blog-post/cms-contrast-supervision-2026-virtual-direct-supervision-authorized-as-permanent ContrastConnect City: Las Vegas Address: Las vegas Website: https://www.contrast-connect.com/

Jim Rucinski, Solution Engineer at the International Fresh Produce Association, runs IFPA's entire digital experience with a team of two — personalization, content management, and platform support included.He joins Greg Kihlström at Opticon to walk through what a constraint that tight actually forces you to decide.A two-person team changes the question from what to build to what to refuse. Ruckinski on the test he applies when a request lands, and how much of the week is already claimed by maintenance before anything new gets considered.Handing content tools to non-technical colleagues means handing out the ability to break consistency. What had to be standardized inside Optimizely's CMS and Content Marketing Platform before the organization could self-serve without the experience coming apart."AI" covers both a faster draft and a system that executes on its own — and a lean team can only absorb one of them. How Rucinski separates technology that removes work from technology that adds something new to supervise.About Jim RucinskiJim Rucinski is the Solutions Engineer at the International Fresh Produce Association (IFPA), where he oversees the evolution of the organization's enterprise digital ecosystem. A self-taught programmer with more than 30 years of software engineering experience, Jim specializes in turning operational friction into automated, reusable capabilities. Partnering with solution provider Perficient, he focuses on leveraging modern CMS architecture, GraphQL, and practical AI tools to run a global digital presence efficiently.Jim Rucinski on LinkedIn: https://www.linkedin.com/in/jim-rucinski-925004258/---------- Resources ---------- : https://www.freshproduce.com/The Agile Brand podcast is brought to you by TEKsystems. Learn more here: https://aglbrnd.co/r/2868abd8085a9703We're proud to be a media partner for #MAICON26 - Oct. 13-15! Learn how AI can power your marketing and business and help you grow smarter. Use code AGILE150 to save! https://aglbrnd.co/r/7fe458ced0f04658Reach your customers with Reddit. Spend $500 in ad spend, get $500 back in ad credit! Learn more: https://advertalize.com/r/491818c79fb1873fChaser is the only Slack-native project management platform that helps teams turn messages into tracked tasks, automate follow-ups, and maintain team-wide visibility, without adopting another tool. Now integrated with Claude and other GenAI tools. Learn more at trychaser.com and use code AGILEBRAND for a 3-month free trial (normal trial is 14 days).The most influential minds in software, AI, and engineering leadership will be at WeAreDevelopers World Congress North America, September 23-25 in San Jose. Learn more: https://aglbrnd.co/r/60a7299222a7bcf1Start building your own apps with Replit and get $20 off. Learn more: https://aglbrnd.co/r/93531742a7625a20Enjoyed the show? Tell us more at and give us a rating so others can find the show at: https://aglbrnd.co/r/faaed112fc9887f3Connect with Greg on LinkedIn: https://www.linkedin.com/in/gregkihlstromDon't miss a thing: get the latest episodes, sign up for our newsletter and more: https://aglbrnd.co/r/35ded3ccfb6716baCheck out The Agile Brand Guide website with articles, insights, and Martechipedia, the wiki for marketing technology: https://www.agilebrandguide.comThe Agile Brand is produced by Missing Link—a Latina-owned strategy-driven, creatively fueled production co-op. From ideation to creation, they craft human connections through intelligent, engaging and informative content. https://www.missinglink.company Hosted on Acast. See acast.com/privacy for more information.

Why do physical therapy clinics feel broken even when everyone seems to be working harder?On this episode of PT Breakfast Club, Jimmy McKay, Tony Maritato, and Dave Kittle dig into physical therapist hiring, clinician recruitment, clinic marketing, reimbursement, RTM, AI-driven efficiency, and the economics of running a PT practice.The conversation starts with a simple hiring problem: most clinics are competing for the same physical therapists using the same job boards, the same bonuses, and the same messaging. If every clinic is fishing in the same pond, is doing more of the same actually a strategy?Then the conversation turns to marketing, attention, trust, and why a local pancake shop may understand brand building better than most healthcare organizations.Finally, the guys explore a bigger question for physical therapy: when technology makes care more efficient and less expensive to deliver, who actually captures that value? The clinician? The clinic? The patient? Or the payer?Topics include:• Physical therapist hiring and recruitment• PT clinic staffing challenges• Physical therapy job marketing• Clinician retention and hiring strategy• RTM and remote therapeutic monitoring• CMS and physical therapy reimbursement• AI and healthcare efficiency• Private practice physical therapy• PT clinic marketing• The economics of physical therapy practiceThe big takeaway: you may not need more applicants, more marketing, or more of the same strategy. You may need to play a different game.

TWIRx NEWS 1. Medicare Part D Paid Nearly $588 Million for Ineligible OTC Drugs   A federal audit found that Medicare Part D sponsors made approximately $587.7 million in ineligible payments from 2021 through 2023 for medications that had effectively transitioned from prescription to over-the-counter status.   The HHS Office of Inspector General cited outdated FDA information and the lack of a clear CMS rejection timeline as major contributors.   Why it matters: This exposes a serious coordination problem across FDA data, manufacturers, CMS, health plans and pharmacy claims systems.   Pharmacists may see the rejection or payment issue at the counter, but the failure often begins far upstream.   Read the Fierce Healthcare report Read the HHS-OIG audit 2. FDA Responds to Estradiol Patch Supply Pressure   The FDA is working with six manufacturers to improve access to estradiol transdermal patches amid increased demand.   While FDA has not declared a national shortage, availability varies by product, strength and geographic area. Manufacturers are increasing production through larger batches, added shifts and expanded capacity.   Why it matters: Pharmacists are again serving as the front line of a supply-chain challenge—helping patients locate medication, coordinating with prescribers and identifying alternatives.   Read the Reuters report Read the FDA update 3. New RSV and COVID-19 Guidance Released   The American Academy of Pediatrics and American College of Obstetricians and Gynecologists have issued updated recommendations for RSV and COVID-19 protection during the 2026–2027 respiratory season.   Why it matters: Pharmacists may face conflicting recommendations, patient confusion and questions about eligibility.   Clear counseling and coordination with pediatric and obstetric providers will be critical.   Read the Pharmacy Times report SPECIAL ANNOUNCEMENT FROM OUTCOMES   A special update from Megan Urban and Outcomes.   Outcomes is highlighting new enhancements to its Rx30 pharmacy management platform, including a refreshed user experience, automated data-entry capabilities and support from a dedicated Client Success Team.   The program will explore how these updates can streamline pharmacy workflows, save time and support greater focus on patient care.   Presented by: Dalia Rios and Kaley Lester September 9, 2026 — 1:30 p.m. ET   Register here FEATURED CONVERSATION Building a Bridge to GLP-1 Access   Our featured guest is HaVy Ngo-Hamilton, PharmD, RPh, Senior Pharmacy Director at Buzz Health.   HaVy works at the intersection of pharmacy, healthcare technology, medication affordability and prescription access.   Buzz Health operates platforms including BuzzRx, RxCompare and RxAffect, with a focus on helping connect patients, pharmacies, prescribers and prescription pricing information.   That makes today's discussion particularly timely. THE MEDICARE GLP-1 BRIDGE   CMS launched the Medicare GLP-1 Bridge on July 1, 2026, to provide eligible Medicare Part D beneficiaries access to selected GLP-1 medications for weight management.   The demonstration runs through December 31, 2027.   Eligible beneficiaries pay $50 for a monthly supply, while the program operates outside the traditional Part D payment flow through centralized prior authorization, claims adjudication and pharmacy payment.   Eligible therapies currently include:   Foundayo® Wegovy® Zepbound®   The bigger issue is not simply GLP-1 coverage.   It is how healthcare connects eligibility, affordability, prior authorization, pharmacy workflow and patient access.   The central question for today's discussion:   Can we create a medication-access system where patients know whether they can obtain and afford their therapy before they reach the pharmacy counter? CLOSING THOUGHT   The Medicare GLP-1 Bridge is more than another federal drug program.   It is a real-world test of how healthcare can better connect coverage, affordability, prior authorization and pharmacy fulfillment around high-demand therapies.   Pharmacists remain at the center of that process.   The opportunity is to use technology to move more complexity upstream—allowing pharmacists to spend less time troubleshooting prescriptions and more time caring for patients.   Our thanks to HaVy Ngo-Hamilton, PharmD, RPh, Senior Pharmacy Director at Buzz Health, for joining us on This Week in Pharmacy.   Learn more about the CMS Medicare GLP-1 Bridge   Learn more about Buzz Health   TWIRx — This Week in Pharmacy Pharmacy Podcast Network   Amplifying the Voice of Pharmacy.

This episode is sponsored by BONESUPPORT™, maker of CERAMENT® G with Gentamicin – the one and only FDA authorized, antibiotic-eluting bone void filler. For more information, visit https://www.bonesupport.com/en-us/products/cerament-g/  Paul Matuszewski, MD, from University of Kentucky is joined by Chris Cosgrove, MD and Peter Everson, MD to discuss how they're using new technology and evidence to best care for their patients in today's cost-conscious landscape.  Over the course of forty minutes, they discuss their move towards single-stage surgeries, shortened antibiotic treatment regimens, and how they're even treating some of their patients outpatient with CERAMENT G. They also discuss the new CMS ruling for FY2027 and what it means for CERAMENT G.      Interested in staying in touch? Follow BONESUPPORT on LinkedIn https://www.linkedin.com/company/bonesupport-ab/   References discussed in this episode:  · Conway J, et al. 'Antibiotic Cement-Coated Rods.' Bone Joint J. vol. 96-B, no. 10, 2014, pp. 1349-1354. doi:10.1302/0301-620X.96B10.33799.  · McNally et al. 'Single-stage treatment of chronic osteomyelitis with a new absorbable, gentamicin-loaded, calcium sulphate/hydroxyapatite biocomposite: a prospective series of 100 cases.' Bone Joint J. 2016;98-B(9):1289-96  · Godina M. Early microsurgical reconstruction of complex trauma of the extremities. Plast Reconstr Surg. 1986;78(3):285-292. doi:10.1097/00006534-198609000-00001  · McNally et al. 'Mid- to long-term results of single-stage surgery for patients with chronic osteomyelitis using a bioabsorbable gentamicin-loaded ceramic carrier.' Bone Joint J. 2022;104-B(9):1095-1100.  · Ferguson J et al., 'A Comparison of Clinical and Radiological Outcomes between Two Different Biodegradable Local Antibiotic Carriers Used in the Single- ­stage Surgical Management of Long Bone Osteomyelitis', Bone & Joint Research, 2023; 12(7): 412–22  · Henry et al., 'Long-Term Follow-Up of Open Gustilo-Anderson IIIB Fractures Treated With an Adjuvant Local Antibiotic Hydroxyapatite Bio-Composite', Cureus. 2023; 15(5).   · Li et al. 'Oral versus Intravenous Antibiotics for Bone and Joint Infection.' The New England Journal of Medicine, 2019; 380:425-436  · Major Extremity Trauma Research Consortium (METRC).  'Oral vs intravenous antibiotics for fracture-related infections: the POvIV randomized clinical trial.'  JAMA Surg. 2025;160(3):276-284.  Information discussed regarding CMS:   · Centers for Medicare & Medicaid Services (US). Medicare program; hospital inpatient prospective payment systems for acute care hospitals (IPPS) and the long-term care hospital prospective payment system and policy changes and fiscal year (FY) 2027 rates; requirements for quality programs; other policy changes; and adoption of updated versions of certain health information technology standards. Final rule (CMS-1849-F) [Internet]. Fed Regist. 2026 Aug 4 [cited 2026 Aug 20]. Available from: https://www.federalregister.gov/documents/2026/08/04/2026-15833/medicare-program-hospital-inpatient…. Also available from: https://www.govinfo.gov/content/pkg/FR-2026-08-04/pdf/2026-15833.pdf

Send us Fan MailThe hospice moratorium may eventually end—but CMS scrutiny of hospice is likely here to stay.In Part Two of The Hospice Moratorium: What CMS Is Really Signaling About the Future, Chris Comeaux and Cordt Kassner continue their conversation with Dr. Jennifer Kennedy, Vice President for Quality, Standards and Compliance at CHAP, about what hospice leaders should expect when the moratorium is lifted—and how organizations should prepare now.The conversation explores increased CMS enrollment scrutiny, changes of ownership, audits, SSVI, compliance programs, and the growing role of data and AI in identifying fraud and abuse.  Jennifer emphasizes that quality and compliance must work hand-in-hand and that hospices should begin treating audits and regulatory readiness as part of the cost of doing business. But greater regulation raises an important question: Can CMS become precise enough to eliminate bad actors without penalizing high-quality providers? The discussion examines how better data and AI could help regulators target fraud more effectively while protecting access, innovation, and legitimate hospice organizations. Most importantly, Jennifer reminds leaders that compliance cannot overshadow the mission.  Even in a more regulated future, hospice must remain centered on compassionate, patient-centered care and what matters most to the patient. In this episode:What could happen when the hospice moratorium endsWhy CMS scrutiny is likely to increaseBuilding a culture of compliance and qualityWhy hospices should budget for more auditsSSVI and the future of hospice oversightUsing AI and data to better identify fraud and abuseProtecting legitimate providers from regulatory overreachKeeping compassion at the center of hospice care

The hospice moratorium may eventually end—but CMS scrutiny of hospice is likely here to stay.In Part Two of The Hospice Moratorium: What CMS Is Really Signaling About the Future, Chris Comeaux and Cordt Kassner continue their conversation with Dr. Jennifer Kennedy, Vice President for Quality, Standards and Compliance at CHAP, about what hospice leaders should expect when the moratorium is lifted—and how organizations should prepare now.The conversation explores increased CMS enrollment scrutiny, changes of ownership, audits, SSVI, compliance programs, and the growing role of data and AI in identifying fraud and abuse.  Jennifer emphasizes that quality and compliance must work hand-in-hand and that hospices should begin treating audits and regulatory readiness as part of the cost of doing business. But greater regulation raises an important question: Can CMS become precise enough to eliminate bad actors without penalizing high-quality providers? The discussion examines how better data and AI could help regulators target fraud more effectively while protecting access, innovation, and legitimate hospice organizations. Most importantly, Jennifer reminds leaders that compliance cannot overshadow the mission.  Even in a more regulated future, hospice must remain centered on compassionate, patient-centered care and what matters most to the patient. In this episode:What could happen when the hospice moratorium endsWhy CMS scrutiny is likely to increaseBuilding a culture of compliance and qualityWhy hospices should budget for more auditsSSVI and the future of hospice oversightUsing AI and data to better identify fraud and abuseProtecting legitimate providers from regulatory overreachKeeping compassion at the center of hospice care

GLP-1 receptor agonists (the "Ozempics of the world") have been a truly revolutionary pharmacological advance in modern medicine. In randomized controlled trials (RCTs), these agents have been shown to do much more than just reduce weight, including significantly reducing cardiovascular events, lowering all-cause mortality in patients with type 2 diabetes, and even slowing the progression of chronic kidney disease. But as we see their use rapidly expand among older adults, we have to ask: at what cost? In geriatrics, weight loss is rarely simple. In older bodies, GLP1s carry increased risks, including accelerated muscle loss, functional decline, and possibly decreased bone density. So are we just trading weight loss for frailty? To help us untangle this complex web, we sit down with three expert geriatricians in obesity: Dr. John Batsis, Dr. Shen Dewar, and Dr. Aruna Josyula. What We Discuss in This Episode: How age-related changes alter the distribution of fat and muscle, even when body weight stays exactly the same. What are sarcopenia (muscle loss) and sarcopenic obesity, and why are they so dangerous for independence? A discussion on what happens to fat, muscle, and bone during standard weight loss versus weight loss accelerated by GLP-1s. Whether GLP-1-induced muscle loss a direct biological side effect from suppressed muscle protein synthesis, or is it simply the indirect result of a massive caloric deficit and dropping protein intake? A broad, geriatric-focused approach to weight, including a vital review of common medications that might actually be causing weight gain in the first place. Practical, actionable strategies to protect muscle mass and function when prescribing GLP1s A discussion of red flags in older adults, where we should have major hesitation before ever writing a prescription for a GLP-1 We cover this and more in the podcast. There is a forthcoming article in JAGS that addresses this topic, and we will add the link here once published.  If you want to take a deeper dive, take a look at some of the following references we discuss: Aruna's article in JAGS titled "One Size Fits None: Developing a Person-Centered Approach to Weight Management in Older Adults" John's Annal's article on the "Effect of Incretin-Based and Nonpharmacologic Weight Loss on Body Composition: A Systematic Review" John's article on the "Unintended risks of sarcopenic obesity during weight-loss interventions in older people" in Nature Med.   An article titled "The Effects of Incretin Mimetic Therapies on Muscle and Bone Health in Older Adults" A systematic review of the effect of weight loss on muscle-based indices An article on "Treating Sarcopenic Obesity in the Era of Incretin Therapies: Perspectives and Challenges" Shen's article describing "The Optimal Health Weight and Lifestyle (OHWL) Clinic" Shen's article titled "A Geriatrician's Approach to Managing the Complex Older Adult with Obesity" Another JAGs article on "Older Adults with Obesity: The Need for a 4Ms Age-Friendly Approach to Care" Lastly, CMS's information on the GLP1 bridge program  

Let us know how you're enjoying the show or ideas for any future topics!In this episode of "It's Settled", Shawn Deane sits down with Parashar Patel to discuss the lasting impact of the 2001 “Patel Memo,” a CMS policy memo that became a foundational document in the Medicare Set-Aside industry. Recorded on the memo's 25th anniversary, the conversation looks back at how a document intended to answer routine policy questions grew into one of the most recognized references in the workers' compensation and Medicare space. Patel shares his memories of working at CMS at the time and explains that the memo was designed to provide consistent guidance to regional offices handling questions about workers' compensation settlements and Medicare. This episode explores how the memo helped bring clarity to the process of protecting Medicare's interests when injured workers settle claims that include future medical expenses. Patel discusses the policy environment at CMS in the early 2000s, the reasons the memo was created, and why he is still surprised by the attention it receives decades later. They also consider how the industry might have evolved if CMS had never issued the guidance and discuss the balance between clear regulations and agency flexibility when addressing complex healthcare issues.The episode also provides a personal look at Patel's career, from his work in healthcare policy at CMS to his later roles in the medical device industry and consulting. In a humble reflection, Patel notes that the memo was the result of a team effort and gives credit to colleagues who helped draft and develop the guidance. Overall, the conversation offers listeners a unique perspective on the history of Medicare Set-Asides and the people behind one of the industry's most influential policy documents.Ametros is changing the way injured individuals navigate healthcare by providing them with post-settlement medical management tools for their settlement funds. Ametros helps drive more simplified, secured, and supported settlements and saves money by working closely with injured workers, insurers, employers, attorneys, and Medicare to create a seamless experience.Learn how Ametros can support you.

Send us Fan MailThe hospice moratorium may be temporary—but the changes it signals for hospice oversight could be permanent.In Part One of The Hospice Moratorium: What CMS Is Really Signaling About the Future, Chris Comeaux and Cordt Kassner, PhD, are joined by Dr. Jennifer Kennedy, Vice President for Quality, Standards and Compliance at CHAP, to unpack why CMS implemented the hospice moratorium and what it could mean for the future of the Medicare hospice benefit.The conversation explores the growing federal focus on fraud and abuse, rapid hospice market expansion, Medicare enrollment, accreditation oversight, and increasingly sophisticated screening of providers.  Jennifer also explains why she believes the moratorium could be extended—and why CMS scrutiny is unlikely to disappear when the moratorium eventually ends. But there's another side to the crackdown: legitimate hospice providers can get caught in the same regulatory net designed to stop bad actors.  What happens when high-quality organizations want to expand into rural or underserved communities but can't? And can CMS become precise enough to protect access while aggressively pursuing fraud? In this episode:What the CMS hospice moratorium actually meansWhy fraud and rapid market expansion triggered increased scrutinyWhether the moratorium could be extendedThe role of accreditation and enrollment screeningHow legitimate hospice providers may be unintentionally affectedWhy quality and compliance will define the next era of hospice oversight Guest: Dr. Jennifer Kennedy, Vice President, Quality, Compliance and Standards with CHAPCo-Host: Cordt Kassner, PHD, Publisher, Hospice & Palliative Care TodayHost: Chris Comeaux, President / CEO of Teleios, author of The Anatomy of LeadershipThe Anatomy of Leadership podcast explores the art and science of leadership through candid, insightful conversations with thought leaders, innovators, and change-makers from a variety of industries. Hosted by Chris Comeaux, each episode dives into the mindsets, habits, and strategies that empower leaders to thrive in complex, fast-changing environments. With topics ranging from organizational culture and emotional intelligence to navigating disruption and inspiring teams, the show blends real-world stories with practical takeaways. The goal is simple yet ambitious: to equip leaders at every level with the tools, perspectives, and inspiration they need to lead with vision, empathy, and impact.https://www.teleioscn.org/anatomy-of-leadership

The hospice moratorium may be temporary—but the changes it signals for hospice oversight could be permanent.In Part One of The Hospice Moratorium: What CMS Is Really Signaling About the Future, Chris Comeaux and Cordt Kassner, PhD, are joined by Dr. Jennifer Kennedy, Vice President for Quality, Standards and Compliance at CHAP, to unpack why CMS implemented the hospice moratorium and what it could mean for the future of the Medicare hospice benefit.The conversation explores the growing federal focus on fraud and abuse, rapid hospice market expansion, Medicare enrollment, accreditation oversight, and increasingly sophisticated screening of providers.  Jennifer also explains why she believes the moratorium could be extended—and why CMS scrutiny is unlikely to disappear when the moratorium eventually ends. But there's another side to the crackdown: legitimate hospice providers can get caught in the same regulatory net designed to stop bad actors.  What happens when high-quality organizations want to expand into rural or underserved communities but can't? And can CMS become precise enough to protect access while aggressively pursuing fraud? In this episode:What the CMS hospice moratorium actually meansWhy fraud and rapid market expansion triggered increased scrutinyWhether the moratorium could be extendedThe role of accreditation and enrollment screeningHow legitimate hospice providers may be unintentionally affectedWhy quality and compliance will define the next era of hospice oversight Guest: Dr. Jennifer Kennedy,Co-Host: Cordt Kassner, PHD, Publisher, Hospice & Palliative Care TodayHost: Chris Comeaux, President / CEO of Teleios, author of The Anatomy of LeadershipTeleios Collaborative Network   /   https://www.teleioscn.org/tcntalkspodcast

The Nurses Report on America Out Loud with Gail Macrae, BSN, RN – That system is four agencies working in concert. NIH funds the papers that supply the narrative. CDC turns the narrative into recommendations. CMS attaches the money. FDA supplies the EUA that makes the whole chain legally possible. It is a network. Subpoena power exists to pull the records those agencies already...

On this episode of Diabetes Connections In the news… The FDA approves a new indication and health benefit for Mounjaro, lots of CGM news including an update on Medicare coverage for people who don't use insulin and a new study about using CGM when you don't have diabetes, metformin and aging, statins and type 2, and did you know there was a Dolly Parton diabetes connections? That and much more... Check out all of our events like Moms' Night Out and Club 1921 here. Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  On this episode of Diabetes Connections In the news… The FDA approves a new indication and health benefit for Mounjaro, lots of CGM news including an update on Medicare coverage for people who don't use insulin and a new study about using CGM when you don't have diabetes, metformin and aging, statins and type 2, and did you know there was a Dolly Parton diabetes connections? That and much more.. that's coming up right after this. (AD BREAK) Welcome! I'm your host Stacey Simms and this is an In The News episode.. where we bring you the top diabetes stories and headlines happening now. A reminder that you can find the sources and links and a transcript and more info for every story mentioned here in the show notes. Welcome to September! Want to let you know about a webinar I'm doing with Abbott later this month. That's Sept 23 at 7pm ET. We'll be talking about ketones, DKA and learn more about their dual CGM/ketone monitor that was just approved – more on that coming up. But please register – the link is in the show notes. So much going on over here – tomorrow night we have our Club 1921 in Charlotte, later this month Moms' Night Out Detroit/Bloomfield and in October we're going to Seattle. Please join us. More at d-c dot com slash events. Okay.. our top story this week: XX Another indication for Mounjaro – the FDA approved it to lower the risk of major adverse cardiovascular (CV) events (MACE), including CV death, non-fatal heart attack, or non-fatal stroke in adults with type 2 diabetes who are at high risk for these events. Mounjaro – the brand name of tirzepatide - is already approved as an adjunct to diet and exercise to improve blood sugar in adults and children 10 years of age and older with type 2 diabetes. The approval was based on results from the largest and longest tirzepatide study to date, enrolling more than 13,000 participants across 30 countries over more than four and a half years. In the trial, Mounjaro demonstrated non-inferiority to Trulicity (dulaglutide), a GLP-1 treatment with established cardiovascular benefit, with an 8% lower rate of cardiovascular death, heart attack or stroke (MACE-3). The estimated hazard ratio for time to first MACE was 0.92 (95.3% CI: 0.83, 1.01) for Mounjaro compared to Trulicity (dulaglutide). https://www.prnewswire.com/news-releases/fda-approves-lillys-mounjaro-tirzepatide-to-reduce-cardiovascular-risk-in-adults-with-type-2-diabetes-302862415.html XX The FDA approves the Libre Duo – the first device designed to continuously monitor both blood sugar levels and ketone levels in people with diabetes. The Libre Duo 10-Day Continuous Dual Glucose Ketone Monitoring System is now approved for those ages 2 and older. Until now, the agency said, people had to monitor ketone levels with separate tests that only provided a single measurement at one point in time. The new system combines blood sugar and ketone tests and monitors them continuously. Readings -- and alerts in case of dangerous trends -- are sent wirelessly to a smartphone app. The FDA previously granted "breakthrough device" status to the system, which is meant to expedite the device's development and review. https://www.upi.com/Top_News/US/2026/08/25/fda-oks-blood-sugar-ketone-monitor/5521787688375/ XX Diabetes tech firms Dexcom and Abbott are watching closely for a Medicare coverage expansion that could significantly broaden access to their glucose sensors. The Centers for Medicare and Medicaid Services is expected to expand Medicare coverage of continuous glucose monitors to people with diabetes who do not take insulin. Currently, coverage is limited to people with Type 1 or Type 2 diabetes who take insulin or have a history of problematic low blood sugar. Dexcom CEO Jake Leach told investors in a late July earnings call that the company expects to hear back from the CMS before the end of the year, with coverage going into effect in mid-2027.     Dexcom presented results of a randomized, controlled trial earlier this summer at the American Diabetes Association's Scientific Sessions that it expects will support the CMS' decision. The 26-week study found that people who used a CGM had a larger hemoglobin A1C reduction than the control group and spent five more hours per day in a normal glucose range than the control group. https://www.medtechdive.com/news/dexcom-abbott-await-medicare-coverage-expansion-for-cgms/828775/ XX A new study suggests continuous glucose monitors (CGMs) may offer benefits for people with type 1 diabetes that go beyond improving blood sugar and reducing hypoglycemia.   Researchers analyzed health records from more than 8,400 adults with type 1 diabetes receiving care through the Veterans Health Administration. Over one to four years of follow-up, people who started using a CGM had a 10% to 16% lower risk of death from any cause compared with those who did not use one.   The association appeared strongest among people over age 65 and those who were not using insulin pumps. Researchers did not find meaningful differences based on A1C, race or ethnicity, or frailty.   Importantly, this was an observational study using medical records, not a randomized clinical trial, so it cannot prove that CGM use directly caused the lower death rate. But the findings suggest CGM may have important long-term health benefits beyond glucose management.https://visualize.jove.com/42319755-continuous-glucose-monitoring-initiation-is-associated-with-reduced-mortality-in-older-onset-type-1-diabetes-patients-a-target-trial-emulation-study-within-the-veterans-health-administration XX We've been talking about people without diabetes using CGMs for a long time.. now a new study weighs in. Research published in JAMA finds that this wellness trend isn't helpful for people without a diabetes diagnosis. They found that the strongest evidence for CGM use is for people who are already living with diabetes, but not for those without the condition who use them for wellness purposes. It's also worth noting, though, that this new study is a narrative review. This means that the researchers drew their conclusions from the findings reported in several other studies. More randomized controlled trials would be necessary to see whether there are any meaningful health benefits of using a CGM if you don't have diabetes.   Dower also warned that constantly monitoring your blood sugar when you don't have diabetes could lead to unintended health anxiety. In some cases, you may even make accidental lifestyle changes that could be harmful. "[Blood sugar] spikes may occur after meals, but if this leads someone to replace healthy food such as fruit with unhealthy food such as something high in fat but low in carbohydrate, the glucose information has done more harm than good," Dower said. https://www.verywellhealth.com/blood-sugar-monitor-for-people-without-diabetes-12058575   XX   Could metformin somehow influence the biological processes that drive aging? A new review found evidence that metformin may affect several key features of aging, including how cells use energy, inflammation, cellular damage and even some changes in gene activity. Animal studies have shown longer lifespans or improvements in markers of biological aging, while some human studies have also found promising results.   But researchers say there's still no proof that metformin actually slows aging or helps healthy people live longer. Most human research has involved people with diabetes or other health conditions, and one large trial found that while metformin helped prevent type 2 diabetes, it did not reduce cancer, cardiovascular disease or deaths.   Researchers say larger clinical trials in people without diabetes are needed to determine whether metformin can truly extend healthy lifespan—or whether its benefits are primarily related to preventing and treating specific diseases. https://www.technologynetworks.com/drug-discovery/news/metformin-may-influence-longevity-through-the-gut-microbiome-and-epigenetic-changes-416035 XX More to come including more research on a spice thought to help diabetes, predictions about the number of people who may be living with type 1 in the years to come around the world, and a connection I didn't know about between diabetes and Dolly Parton.   XX A compound found in turmeric may help protect blood vessels from some of the damage caused by Type 1 diabetes. In rats, curcumin reduced inflammation, improved cellular signaling, and restored vascular health to levels resembling those of nondiabetic animals. The results hint at a possible new way to reduce the long-term cardiovascular risks of diabetes, but human trials are still needed. Curcumin, the natural compound responsible for turmeric's vivid yellow color, is widely studied for its anti-inflammatory and antioxidant properties. https://www.sciencedaily.com/releases/2026/08/260824065543.htm XX New research estimates the number of people living with type 1 diabetes (T1D) worldwide will increase by 29% from 9.4 million in 2025 to 12.1 million in 2049. This will be presented at EASD, the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2 The USA will see an increase of over half a million, going from 1,492,825 to 2,055,235. The authors suggest that the reasons for the predicted high incidence and prevalence in 2049 in countries such as Australia, US, UK are likely to be a combination of genetics, environmental triggers and also high case detection rates (due to the good health care infrastructure here and in other HIC). Unlike previous estimates, the DIAMOND-T1D model takes historical patterns of insulin availability into account and aims to provide global, regional and country-specific estimates of T1D incidence, prevalence and mortality from 1900 to 2050. Although the majority of people with T1D live in high-income countries (HIC) and middle-income countries (MIC), the largest relative increase in the T1D prevalence is expected to occur in LIC as access to insulin, glucose monitoring and survival all improve in those countries. https://www.news-medical.net/news/20260828/Type-1-diabetes-cases-projected-to-increase-worldwide-by-2049.aspx XX Early initiation of statins after a diagnosis of type 2 diabetes was associated with a lower risk of dementia, according to a study published in The Lancet Regional Health – Europe. According to the Lancet Commission, nearly half of dementia cases could theoretically be prevented by eliminating 14 risk factors. "Detecting and treating high levels of low-density lipoprotein cholesterol (LDL-C) from midlife is one such highlighted risk factor," From Danish registers, researchers identified 132,585 statin-naive individuals who developed type 2 diabetes from 2006 through 2019, with follow-up until the end of 2021.   Medical records were searched for diagnoses of all-cause dementia. A clone-censor-weight design was used to analyze dementia incidence in patients with no statin initiation within five years after diagnosis, in those with early statin initiation within one year and in those with late statin initiation between one and five years after diagnosis.   https://medicalxpress.com/news/2026-08-early-statins-diagnosis-diabetes-dementia.html   XX We are heartbroken over the loss of our friend Dolly Parton. Dolly was a beloved icon whose extraordinary generosity, warmth, and compassion touched countless lives, including those of the Children's Diabetes Foundation and the Barbara Davis Center for Diabetes. Her support of The Carousel Ball and Carousel of Hope Ball reflected her deep commitment to helping children and families affected by type 1 diabetes. Beyond her remarkable talent, Dolly will be remembered for the kindness and joy she shared so generously with others. Our hearts are with her family, friends, and all who loved her as we celebrate her extraordinary life and lasting legacy. She will be deeply missed.    

Recorded live at Shopware Partner Day in Austin, Texas on April 22, 2026.Mark Stanley is Shopware's chief product and technology officer, where he looks after all product development. He walks through what is landing this year. Shopware's own native PaaS has just gone GA, highly opinionated and driven from the command line. An intelligence suite is in progress, bringing AI into bulk editing, CMS content generation and store data insights. And Nexus, an orchestration system for connecting Shopware instances to each other and to third party systems, goes GA at Shopware Community Day in Cologne.His hot take is data sovereignty, and business model sovereignty with it. More SaaS providers want to hoover up as much data as they can get, which suits a merchant who wants one button to push. Merchants thinking further out want to keep control of where the business model lives and where the proprietary data sits. His advice is to work out what you would not want an LLM to be able to copy in two or three years, and protect that. The moats are changing.On partners, he sees the job shifting away from shipping features and toward delivering outcomes, with tokens becoming the unit of outcome usage. On AI, he is most interested in developer tooling, where the first 80 percent of a build can happen in 20 percent of the time while the last 20 percent stays human work. And he thinks a portion of shopping stays tactile, digitally or physically, the way asking Siri to play something is a different experience from browsing Spotify.On North America he calls it an underdog story. Shopware is the Linux to the Windows and the Android to the iOS, and the work is the ground game, the same way it was done in Europe fifteen years ago. Bring a case of beer, go on the road, get people to join the ride.Shopware Community Day runs June 10 in Cologne. Shoptoberfest runs September 14 and 15 in Nashville.Learn more about our at-event interviews at talk-commerce.com/events.

This week I Talk About Accessibility After Launch [powerpress]

This week I Talk About Accessibility After Launch [powerpress]

The CMS board votes to release a summary of its recent investigation into Superintendent Crystal Hill. Former U.S. Border Patrol Commander-at-Large Greg Bovino stops by east Charlotte, using anti-immigrant language and pushing for more deportations. And U.S. Sen. Darline Graham wins a GOP primary runoff in South Carolina.

The 2027 Physician Fee Schedule signals a continued restructuring of clinician payment-redistributing funds towards primary care and behavioral health while providing signals for what's coming next.OTs and PTs can no longer sit on the sidelines. As straightforward, low-complexity care increasingly moves toward digital pathways and as patients increasingly access care through digital front doors, we must advocate that CMS properly values the high-value cognitive work and in-person, complex clinical reasoning and officially integrates therapy as the missing third pillar of the primary care team. This year's proposed rule is a critical opportunity to provide CMS solutions that can be met by OTs and PTs and advocate for key coding updates: reimbursing existing evaluation codes by complexity level and creating new non-time-based management codes to capture longitudinal care provided by occupational and physical therapists.At OT Potential, we're equipping YOU to raise your voice. In this live webinar and course, we'll spend an hour unpacking the proposed rule, detailing our policy asks, and sharing a simple, plug-and-play comment template so you can submit your own letter to CMS. We'll be led by the incredible Dana Strauss, a doctor of physical therapy and healthcare public policy expert.See full course details here:https://otpotential.com/continuing-education/course/medicare-advocacy-for-2027 See all OT CEU courses here:https://otpotential.com/continuing-educationCheck our our live webinar schedule here:https://otpotential.com/continuing-education/live-webinarsSupport the show by using the OTPOTENTIAL Medbridge Code:https://otpotential.com/blog/promo-code-for-medbridgeTry 2 free OT Potential courses here:https://otpotential.com/free-ot-ceusSupport the show

Health Affairs Publishing's Jeff Byers welcomes Dan Arnold of Brown University to discuss the rapid growth of Medicaid spending on autism treatment and the expanding role of private equity-backed providers in the applied behavior analysis (ABA) therapy market. He explores the drivers behind rising costs, emerging concerns about care quality and fraud, and the challenge of balancing oversight with continued access to services for families.Related Links:The Business Of Autism Treatment: Private Equity Implications For State Medicaid Programs (Health Affairs Forefront)Sign up for Health Affairs' free newsletter to catch up on our new articles, podcasts, and events.

In this special bonus episode of the Science of Skin Podcast, Dr. Patti Farris sits down with Dr. Sandra (Sandy) Johnson — private practice dermatologist in Fort Smith, Arkansas, and member of the American Academy of Dermatology's Board of Directors — for an urgent conversation on the CMS reimbursement cuts threatening the future of dermatology.Dr. Johnson breaks down the three major proposals from CMS that could devastate dermatology practices nationwide: a proposed cut to the 25-modifier that would penalize combined evaluation-and-procedure visits, a potential overhaul of indirect practice expense calculations that could hit dermatology harder than most specialties, and an effort to remove the AMA's RUC representation — stripping physicians of their voice in how reimbursement values are set.Beyond the policy breakdown, Dr. Johnson shares what the AAD is doing to fight back and exactly what members can do right now: submitting the 30-second advocacy letter through Voter Voice, rallying staff and patients to do the same, donating to SkinPAC, and attending this year's Legislative Conference in Washington, DC before the mid-September deadline.This is a call to action for the entire dermatology community — because a united voice is the specialty's best defense.Topics covered:The proposed 9–25% CMS reimbursement cutsThe 25-modifier and what it means for combined visitsIndirect practice expenses and why dermatology may be hit hardestEfforts to remove the AMA from the RUCHow to take action: Voter Voice, SkinPAC, and the AAD Legislative Conference

SLP advocacy can't stop with data. If Medicare reimbursement fails to cover the cost of providing speech-language pathology services, patients and families ultimately feel the impact through longer waitlists, fewer providers, reduced insurance access, and practice closures.In Part 2 of our SPEAK Project series, Jeanette Benigas, PhD/SLP, talks with pediatric occupational therapist and private practice owner Pam Marshall about mobilizing patients and families as part of a larger SLP reimbursement advocacy strategy.After Kentucky therapy providers faced Medicaid reimbursement cuts, Pam helped create a system that made it easy for families to share their individual stories with lawmakers. Her practice generated more than 420 letters in roughly two weeks.Jeanette and Pam discuss how SLPs and practice owners can turn patient experiences into meaningful advocacy, why individual stories matter to policymakers, how practices can make participation easier for families, and why protecting access to speech therapy will require more than SLPs advocating for themselves.The economic data is only one piece of the SPEAK Project. Now we need data, dollars, connections, and people willing to SPEAK.SLP advocacy can't stop with data. If Medicare reimbursement fails to cover the cost of providing speech-language pathology services, patients and families ultimately feel the impact through longer waitlists, fewer providers, reduced insurance access, and practice closures.In Part 2 of our SPEAK Project series, Jeanette Benigas, PhD/SLP, talks with pediatric occupational therapist and private practice owner Pam Marshall about mobilizing patients and families as part of a larger SLP reimbursement advocacy strategy.After Kentucky therapy providers faced Medicaid reimbursement cuts, Pam helped create a system that made it easy for families to share their individual stories with lawmakers. Her practice generated more than 420 letters in roughly two weeks.Jeanette and Pam discuss how SLPs and practice owners can turn patient experiences into meaningful advocacy, why individual stories matter to policymakers, how practices can make participation easier for families, and why protecting access to speech therapy will require more than SLPs advocating for themselves.The economic data is only one piece of the SPEAK Project. Now we need data, dollars, connections, and people willing to SPEAK.Learn more, contribute data, and support the project at SPEAKPROJECT.NET.Get caught up, wherever you stream podcasts!#110: CPT 92507 Is Being Deleted? What Every SLP Must Know About the New Speech Therapy Codes#111: CPT 92507 Q&A for SLPs: Your Questions Answered#113: CPT 92507 Option B: This Is Our Week to Advocate#115: CMS's NEW Pediatric G Code Explained: What Every SLP Needs to Know#116: What the New Speech Therapy Codes Mean for Adult SLPs#117: The End of CPT 92507: Is Your SLP Documentation Ready?#118: It's Time to SPEAK: Part 1 - Building the Data to Fight for SLP Reimbursement✨ Grateful to Chomper Champs for bringing so much positivity and fun to the pediatric SLP space. Follow the link to order the

Topics covered in this episode: Web UIs for your reverse proxy Wagtail 8.0 is hot off the presses RISC-V is now officially supported by CPython Django's annual releases make every version an LTS Extras Joke Watch on YouTube About the show Sponsored by Logfire from Pydantic: pythonbytes.fm/logfire Connect with the hosts Michael: Mastodon / BlueSky / X / LinkedIn Calvin: Mastodon / BlueSky / X / LinkedIn Show: Mastodon / BlueSky / X Join us on YouTube at pythonbytes.fm/live to be part of the audience. Usually Tuesday at 7am PT. Older video versions available there too. Finally, if you want an artisanal, hand-crafted digest of every week of the show notes in email form? Add your name and email to our friends of the show list, we'll never share it. Michael #1: Web UIs for your reverse proxy Traefik, nginx, and Caddy all sit in front of a lot of self-hosted infrastructure, and all three are configured by hand-editing files. Three active projects put a control plane on top: Traefik Manager (Python + Flask), Nginx UI (Go + Vue), and caddy/ui (React + Node). All three are additive rather than replacements - none of them take ownership of your config away from you - which is the part that matters when the thing has write access to production routing. Traefik Manager is the Python one: Flask 3.1 and Gunicorn for the control plane, a lightweight Go agent for remote instances, currently v1.10.0 with an Android companion app. Nginx UI is a single Go binary at 11.3k stars, with a block-style config editor, an Ace editor doing LLM completion on nginx syntax, and an MCP server so agents can drive it. caddy/ui runs as two containers next to your existing Caddy, reads and writes your Caddyfile directly, and uses Caddy's /adapt API to validate before reload - no Docker socket required. Each one edits the config the underlying server already reads, so your files stay the source of truth and you can drop the UI without unwinding anything. Undo is a first-class feature across all three - timestamped backups with optional Git history, config version compare and restore, Caddyfile snapshots with one-click rollback. Observability is where they diverge: Traefik Manager does CrowdSec and a visual route map, Nginx UI does server metrics, caddy/ui streams access logs over SSE and pulls p50/p95/p99 off Caddy's Prometheus endpoint. Maturity spread is wide - Nginx UI has 11.3k stars, caddy/ui has 4 and was built in a single Claude session - and caddy/ui ships with auth off by default, so set CADDY_UI_USER and JWT_SECRET before it goes anywhere near a public interface. Calvin #2: Wagtail 8.0 is hot off the presses Link: https://github.com/wagtail/wagtail/releases/tag/v8.0 Custom base page models are now supported, so projects aren't locked into subclassing Wagtail's Page as shipped (Matt Westcott). New v3 REST API handles both read and write CMS operations, a first for Wagtail's API. A global registry for permission policies, plus full customizability for the remaining page views via PageViewSet. AVIF and WebP images are no longer auto-converted to PNG by default, a real behavior change to watch on upgrade. Five security fixes: page admin API restrictions, document identification by SHA1 hash, descendant collections in the Documents/Images API, snippet copy permissions, and the page translation endpoint. Formalized Django 6.1 support, and CI now runs on uv with a lockfile. Sponsor: Logfire from Pydantic Your AI agent failed at 2am. Was it the model? A tool call? The database? Most observability tools can't tell you, because they only see part of your stack. Pydantic Logfire sees all of it. One trace across your agents, LLMs, APIs, and database. Down to the infrastructure: services, Kubernetes, and hosts. It's built on OpenTelemetry, with SDKs for Python, TypeScript, and Rust, and it works with any OTel-compatible language. Every prompt, token count, and cost, right next to your vector searches and API calls. You query everything with Postgres-compatible SQL. And so can your coding agent, through the Logfire MCP server. Stop guessing. Read the trace. Pydantic Logfire. AI, it's still just engineering. Visit pythonbytes.fm/logfire today and sign up today. Get 10M records free every month, no card required. You can even click “Onboard with your coding agent” to copy a prompt to have claude or codex integrate Logfire into your app. Thanks to Pydantic for supporting the show. Calvin #3: RISC-V is now officially supported by CPython Link: https://blog.python.org/2026/08/riscv-now-officially-supported/ CPython added RISC-V as a tier 3 platform under PEP 11, specifically the 64-bit Linux target riscv64-unknown-linux-gnu. RISC-V is an open ISA anyone can implement, unlike x86 and ARM, and its market is projected to quadruple by 2032. The RISE Project donated real RISC-V machines for buildbots; the author's work was funded by a Sovereign Tech Agency fellowship. What changes: the port is now a maintained compatibility target, so CPython changes are less likely to quietly break it. What doesn't: no python.org installers, no binary wheel parity for native extensions. Next up: RISC-V runners in CPython CI for pre-merge feedback, then a push toward tier 2, plus architecture-specific optimizations. The ask is testing. If you have RISC-V hardware, build CPython, run your test suite, file what breaks. Tier 3 is the weakest support tier. PEP 11 tier 3 requires a core developer contact and a buildbot, but failures on tier 3 platforms explicitly do not block a release. Saying "ongoing CI/testing expectations" oversells it. The honest bit is "someone is now on the hook for it, and breakage gets noticed," not "it's guaranteed working." Worth the caveat that this is Linux SBCs, not microcontrollers. A VisionFive 2 counts, an ESP32-C6 or Pico 2 does not. Those are 32-bit non-Linux parts where MicroPython is still the answer. Michael #4: Django's annual releases make every version an LTS Starting with Django 2028, Django will move to one January feature release per year, adopt calendar-based version numbers, and support every release for three years. The old distinction between standard and LTS releases disappears, giving teams a predictable annual upgrade path that aligns more closely with Python's own release and support cadence. Every Django release becomes the safe, long-supported choice, so teams no longer need to wait for a specially designated LTS version or absorb two years of changes at once. Each release gets one year of mainstream bug fixes followed by two years of security and data-loss fixes. New releases support the three latest Python versions and add the next Python release during their first year. Calendar versioning begins with Django 2028, followed by Django 2029 and so on. Three Django versions will be supported at any time, giving third-party packages a clearer rolling target. Nothing changes before 2028, and existing commitments for Django 5.2 LTS and 6.2 LTS remain in place. Extras Calvin: The Python docs now document the time complexity of built-in types https://docs.python.org/3.16/library/time-complexity.html Thinking in Python - Bruce Eckel's free book https://thinkinginpython.com/ Michael: prune_uv_pythons.py - Prune uv-managed Python installs, keeping only the newest patch per minor version Runs automatically in my system “upgrade” script: upgrade-output-2026.png Started using Ollama cloud models for my Hermes assistant. Thanks to Jeff Triplett I learned they are not just local models. Joke: The Tao of Programming - Book Seven: Corporate Wisdom

The transplant system in America is evolving. And you deserve to know what that means. Today, we unpack the Securing the U.S. Organ Procurement and Transplantation Network (OPTN) Act with experts Miriam Godwin and Jullie Hoggan. Learn why this legislation was introduced, how it could improve the organ transplant system, and what it means for people waiting for or living with a transplant. In this episode we heard from:  Miriam Godwin is a kidney donor and Vice President of Health Policy and Clinical Outcomes at the National Kidney Foundation. She previously led transformative initiatives at CMS, including the ESRD Treatment Choices Model, and supported groundbreaking programs like Kidney Care Choices. With a strong foundation in health policy, clinical trials, and drug development, Miriam has dedicated her career to advancing kidney care and increasing access to transplants. She holds a master's degree in public policy from George Washington University. Jullie Hoggan is the Transplant Director at patients.app and previously co-founded Square Knot Health, where she helped develop a peer-led transplant navigation program alongside a transplant nephrologist. She is also a kidney transplant recipient, bringing both lived experience and professional expertise to her work.  Jullie provides peer mentoring, education, and support to patients, living donors, and care partners through Kidney Solutions. She serves on the OPTN Patient Affairs Committee, the National Kidney Foundation Public Policy Committee, and several other national committees and advisory groups focused on improving transplantation and living donation.   Additional Resources NKF Advocacy Transplantation   Do you have comments, questions, or suggestions? Email us at NKFpodcast@kidney.org. Also, make sure to rate and review us wherever you listen to podcasts.

Terry discusses the 1op 10 Coding Corner Membership questions of the quarter, including Telehealth, the reality of voice recognition transcription disclaimers and some of the new proposals from CMS slated for 2027. Tune in to get the rundown. Subscribe and Listen Find all of Terry’s official links in one place: https://www.terryfletcher.net/links The post Top 10 Tuesday Medical Coding Q and A appeared first on Terry Fletcher Consulting, Inc..

On this episode of The Sean Spicer Show, Sean sits down with Dr. Mehmet Oz, Administrator of the Centers for Medicare & Medicaid Services (CMS), to discuss the growing problem of fraud in Medicare, how scammers are exploiting the system, and what CMS is doing to protect taxpayers and beneficiaries. Then, Evita Duffy-Alfonso joins the show to share highlights from the ultimate Great American Road Trip — traveling across the country with her family and her dad, Transportation Secretary Sean Duffy. https://www.seanspicer.com subscribe for an ad free version of this podcast Bedford Reinforced Plastics - https://www.bedfordreinforced.com/spicer https://ruffgreens.com/⁠ enter code: SPICER for your FREE starter pack Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, Greg and Rob are joined by healthcare attorney Kyle Vasquez to discuss the recently released CMS 2027 OPPS proposed rule. They'll review key provisions in the policy that could impact 340B hospitals, including significant changes to billing requirements, reimbursement rates, and changes to CMS implementation of provider-based criteria for offsite outpatient departments. Earlier in the episode, the guys catch up on 340B news. Questions for us? Email us at 340BUnscripted@spendmend.com

This week I Share My Recap From WordCampUS 2026 [powerpress]

This week I Share My Recap From WordCampUS 2026 [powerpress]